Require the Comptroller General to assess AI in wearable medical devices for clinical decision-making, focusing on treatment accuracy, AI's benefits and challenges, and policy options to enhance benefits and mitigate challenges. Submit findings to Congress within 18 months.
Instructs the Comptroller General of the United States to conduct a technology assessment and submit a report to Congress on wearable medical devices.
Requires the report to assess the capabilities and limitations of these devices in supporting clinical decision-making.
Includes an evaluation of the potential for such devices to accurately prescribe treatments.
Examines the benefits and challenges of integrating artificial intelligence to enhance these devices.
Provides policy options to maximize benefits and mitigate challenges associated with the development or use of wearable medical devices.
This machine-generated summary is awaiting review by an AGORA editor. Use with caution.
This document has not been enacted or otherwise finalized and is subject to change. This summary is based on a copy of the document collected 2025-04-16 - refer to the official source for the most current version.
Key facts
🏛️ This document has been proposed by the United States Congress, but is not yet enacted.
For authoritative text and metadata, visit the official source.
📜 This document's name is Bipartisan Health Care Act.
AGORA also tracks this document under the name Bipartisan Health Care Act, Sec. 217. Report on wearable medical devices.. It is part of Bipartisan Health Care Act.
↳ This document is part of a longer one: Bipartisan Health Care Act.
Some AGORA documents are "split off" from longer documents that mix AI
and non-AI content, such as omnibus authorization or appropriations laws
in the United States Congress. Read more >>
Themes AI risks, applications, governance strategies, and other themes addressed in AGORA documents.
This document has not been enacted or otherwise finalized and is subject to change. This summary is based on a copy of the document collected 2025-04-16 - refer to the official source for the most current version.
Thematic tags are in progress.
Full text
This is an unofficial copy. The document has been
archived and reformatted in plaintext for AGORA. Footnotes, tables, and
similar material may be omitted. For the official text, visit the original source.
This text may be out of date. According to the latest data in AGORA,
this document has been proposed, but is not yet enacted or otherwise
finalized. This text was collected 2025-04-16 and
may have been revised in the meantime. Visit the official source for authoritative text.
SEC. 217. Report on wearable medical devices.
Not later than 18 months after the date of the enactment of this Act, the Comptroller General of the United States shall conduct a technology assessment of, and submit to Congress a report on, the capabilities and limitations of wearable medical devices used to support clinical decision-making. Such report shall include a description of—
(1) the potential for such devices to accurately prescribe treatments;
(2) an examination of the benefits and challenges of artificial intelligence to augment such capabilities; and
(3) policy options to enhance the benefits and mitigate potential challenges of developing or using such devices.
Requires the Comptroller General to report on AI's role in wearable medical devices for clinical decision-making.
Requires the Comptroller General to report on AI's role in wearable medical devices for clinical decision-making.